日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

First-Line Tislelizumab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Cancer: Three-Year Follow-Up of the Phase 3 RATIONALE-309 Randomized Clinical Trial

一线替雷利珠单抗联合化疗治疗复发或转移性鼻咽癌:RATIONALE-309 III期随机临床试验的三年随访

Yang, Yunpeng; Yen, Chia-Jui; Pan, Jianji; Wang, Hui; Qu, Shenhong; Chen, Nianyong; Chen, Xiaozhong; Sun, Yan; He, Xiaohui; Hu, Chaosu; Lin, Lizhu; Wu, Yanjie; Yuan, Shuai; Chen, Chenqi; Xu, Xingxing; Ma, Xiaopeng; Leaw, Shiangjiin; Zhang, Li; Fang, Wenfeng

Five-Year Outcome of Camrelizumab Plus Chemotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Secondary Analysis of the CAPTAIN-1st Randomized Clinical Trial

卡瑞利珠单抗联合化疗治疗复发或转移性鼻咽癌的五年疗效:CAPTAIN-1st随机临床试验的二次分析

Huang, Yan; Sun, Dongchen; Zhou, Huaqiang; Zhou, Ting; Qu, Song; Li, Jingao; Hu, Chaosu; Xu, Mingjun; Li, Weidong; Shen, Liangfang; Wu, Hui; Lang, Jinyi; Hu, Guangyuan; Luo, Zhanxiong; Fu, Zhichao; Qu, Shenhong; Feng, Weineng; Chen, Xiaozhong; Lin, Shaojun; Xie, Bo; Li, Xiaojiang; Sun, Yan; Lin, Zhixiong; Lin, Qin; Lei, Feng; Long, Jianting; Hong, Jinsheng; Huang, Xiaoming; Zeng, Lingzhi; Wang, Peiguo; He, Xiaohui; Zhao, Shen; Chen, Gang; Zhang, Yaxiong; Zhao, Yuanyuan; Fang, Wenfeng; Huang, Chuanpei; Li, Xiaotong; Hong, Shaodong; Zhang, Li; Yang, Yunpeng

Oncolytic virus M1 reinvigorates CD8(+) T-cell immunity against glioblastoma through B-cell-dependent antigen cross-presentation in the spleen.

溶瘤病毒 M1 通过脾脏中 B 细胞依赖性抗原交叉呈递,重新激活 CD8(+) T 细胞对胶质母细胞瘤的免疫力。

Han Yu, Guo Cui, Chen Chaoxin, Yang Wenzhuo, Li Honghui, He Changjia, Deng Jialin, Chen Zhijie, Liu Wenfeng, Chen Jiehong, Zhong Yingqian, Yan Caixin, Xu Cuiying, Liang Xuanming, Zhong Sheng, Chen Furong, Li Depei, Li Cong, Hu Wanming, Chen Zhenghe, Mou Yonggao, Chen Zhongping, Yan Guangmei, Lim Michael, Zhu Wenbo, Sai Ke

Engineered exosome nanovesicles for delivery of antibodies to treat inflammatory bowel disease

工程化外泌体纳米囊泡用于递送抗体以治疗炎症性肠病

Cao, Jiahui; Luo, Ran; Miao, Rourou; Li, Wen; Zhu, Baisong; Yu, Liu; Fu, Yiqiu; Wang, Xinyi; Zhang, Jinxie; Zeng, Wenfeng; Zhang, Hanjie; Mao, Zhuo; Zhang, Fan; Lin, Yao-Xin; Ou, Meitong; Mei, Lin

An alternative EGFR activation by patient-derived R252C mutation promotes cancer progression.

患者来源的 R252C 突变引起的 EGFR 激活可促进癌症进展。

Zhang Yajuan, Fei Qizhen, Li Yan, Wang Siyao, Rong Tong, Wu Xueyuan, Gao Hong, Chen Chen, Gao Dong, Zhao Yun, Li Guohui, Chu Huiying, Li Wenfeng, Yang Weiwei

H3K18 lactylation-mediated SPHK1-SIRT1 feedback loop accelerates pyroptosis of tubular epithelial cells in sepsis-associated acute kidney injury.

H3K18 乳酸化介导的 SPHK1-SIRT1 反馈环加速脓毒症相关急性肾损伤中肾小管上皮细胞的焦亡。

Huang Yan, Zhao Eryang, Zhao Guangyu, Zhuo Wenfeng, Zhao Yingsong, Wang Hongda, Lv Guozheng, Hu Rong, Zeng Zhu, Han Shengbo, Hu Yuhang, Zhao Gang

Histone modification-regulated LncRNA DLEU1 interacts with ASCC2/ALKBH3 complex to drive DNA repair, antioxidant homeostasis and glucose metabolism in gastric cancer.

组蛋白修饰调控的长链非编码RNA DLEU1与ASCC2/ALKBH3复合物相互作用,驱动胃癌中的DNA修复、抗氧化稳态和葡萄糖代谢。

Zhang Xiaoyan, Wang Xin, Wang Qi, Wang Xu, Sun Hui, Liu Yingxue, Tan Cong, Ni Shujuan, Weng Weiwei, Zhang Meng, Wang Lei, Huang Dan, Chen Jie, Wang Xiaoyu, Gan Lu, Abudurexiti Mierxiati, Wang Wenfeng, Chang Jinjia, Sheng Weiqi, Xu Midie

Dual regulation of CXCR6(+)CD8(+) T cells modulates cytotoxic and exhaustion-associated programs during prostate cancer progression.

CXCR6(+)CD8(+) T 细胞的双重调控在前列腺癌进展过程中调节细胞毒性和耗竭相关程序。

Xingming Zhang, Wang Jianhua, Abudurexiti Mierxiati, Du Leilei, Zhang Wei, Ni Xudong, Xu Midie, Zhang Xiaoyan, Zhang Min, Yao Zhu, Bian Xiaojie, Jin Shengming, Wang Wenfeng

SphK1/S1P signaling-mediated crosstalk between pancreatic acinar cell and macrophage M1 polarization aggravates acute pancreatitis progression.

SphK1/S1P信号介导的胰腺腺泡细胞与巨噬细胞M1极化之间的串扰加剧了急性胰腺炎的进展。

Wang Jie, Zhao Guangyu, Hu Ping, Han Shengbo, Hu Yuhang, Zeng Zhu, Li Yang, Zhao Yong, Huang Yan, Zhuo Wenfeng, Lv Guozheng, Wang Hongda, Zhao Gang

Expert consensus on the detection and clinical application of tumor mutational burden

关于肿瘤突变负荷的检测和临床应用的专家共识

Guo, Zhenying; Xu, Chunwei; Zhang, Shirong; Hao, Yue; Hu, Xiaotong; Zhao, Ming; Xiang, Chan; Piao, Yingshi; Sun, Pingli; Xiang, Xueping; Zhao, Jing; Wu, Huanwen; Li, Weixing; Yu, Jinpu; Yuan, Jingping; Wang, Shuangshuang; Wang, Cong; Gu, Yun; Lv, Bingjian; Zhang, Liping; Liu, Yueping; Cui, Xiaobin; Gu, Weizhong; Li, Yining; Wang, Wei; Yang, Wenjun; Long, Weiguo; Xiang, Jingjing; Mou, Hong; Liu, Biao; Ruan, Huajuan; Wang, Yubin; Zhu, Yongjie; Wang, Feng; Wang, Zhonghua; Feng, Xiaomin; Liu, Xing; Li, Peng; Deng, Min; Lian, Bin; Mao, Lili; Wang, Qian; Wang, Wenxian; Song, Zhengbo; Li, Ziming; Zhong, Wenzhao; Wang, Zhijie; Ren, Shengxiang; Fang, Wenfeng; Zhang, Yongchang; Liu, Jingjing; Cai, Xiuyu; Liu, Anwen; Li, Wen; Zhan, Ping; Liu, Hongbing; Lv, Tangfeng; Miao, Liyun; Min, Lingfeng; Chen, Yu; Zhang, Yu; Wang, Feng; Jiang, Zhansheng; Lin, Gen; Huang, Long; Pu, Xingxiang; Lin, Rongbo; Liu, Weifeng; Rao, Chuangzhou; Lv, Dongqing; Yu, Zongyang; Shen, Peng; Li, Xiaoyan; Tang, Chuanhao; Zhou, Chengzhi; Zhang, Junping; Xue, Junli; Guo, Hui; Chu, Qian; Meng, Rui; Wu, Jingxun; Zhang, Rui; Zhou, Jin; Zhu, Zhengfei; Li, Yongheng; Qiu, Hong; Xia, Fan; Lu, Yuanyuan; Chen, Xiaofeng; Ge, Rui; Dai, Enyong; Han, Yu; Zhang, Jian; Ji, Yinghua; Liang, Xianbin; Zhang, Hongmei; Ma, Xuelei; Liu, Xuewen; Yao, Yu; Luo, Peng; Pan, Weiwei; Pang, Fei; Wu, Fan; Gu, Dejian; Wang, Li; Wang, Liping; Zhu, Youcai; Lin, Li; Li, Weiwen; Lin, Xinqing; Cai, Jing; Xu, Ling; Li, Jisheng; Jiao, Xiaodong; Li, Kainan; Wei, Jia; Feng, Huijing; Wang, Lin; Du, Yingying; Yao, Wang; Shi, Xuefei; Niu, Xiaomin; Yuan, Dongmei; Yao, Yanwen; Zhang, Yinbin; Song, Binbin; Li, Wenfeng; Fu, Jianfei; Wang, Hong; Ye, Mingxiang; Wang, Dong; Wang, Zhaofeng; Ji, Qing; Fang, Yuan; Wei, Qing; Wang, Zhen; Wan, Bin; Lv, Donglai; Li, Xiaofeng; Yang, Shengjie; Kang, Jing; Zhang, Jiatao; Zhang, Chao; Shi, Lin; Wang, Yina; Li, Bihui; Zhang, Zhang; Wang, Ke; Liu, Zhefeng; Yang, Nong; Wu, Lin; Chen, Xiaobing; Jin, Gu; Li, Zhongwu; Li, Miao; Wang, Guansong; Wang, Jiandong; Fang, Meiyu; Fang, Yong; Wang, Xiaojia; Chen, Jing; Zhang, Yiping; Zhu, Xixu; Shen, Yi; Ma, Shenglin; Wang, Biyun; Si, Lu; Song, Yong; Lu, Yuanzhi; Liu, Aijun; Han, Yuchen